QAW039
Showing 1 - 19 of 19
COPD Trial in Germany, United Kingdom (QAW039, Placebo)
Terminated
- Chronic Obstructive Pulmonary Disease
- QAW039
- Placebo
-
Frankfurt, Germany
- +3 more
Oct 7, 2021
Renal Insufficiency Trial in Orlando, Grunstadt (QAW039, QAW39A, QAW39A2107)
Completed
- Renal Insufficiency
- QAW039
- +2 more
-
Orlando, Florida
- +1 more
Dec 9, 2020
Persistent Asthma Trial in Worldwide (QAW039 capsules once daily for 28 days, Placebo to QAW039 capsules once daily for 28 days,
Completed
- Persistent Asthma
- QAW039 capsules once daily for 28 days
- +2 more
-
Encinitas, California
- +25 more
Dec 11, 2020
Atopic Asthma Trial in Hannover (Blood Sampling)
Completed
- Atopic Asthma
- Blood Sampling
-
Hannover, Niedersachsen, GermanyFraunhofer ITEM im CRC
Jun 16, 2020
Asthma, Asthma, Bronchial, Bronchial Asthma Trial (QAW039)
Withdrawn
- Asthma
- +4 more
- QAW039
- (no location specified)
May 12, 2020
Asthma Trial in Worldwide (Placebo once daily, QAW039 150 mg once daily, QAW039 450 mg once daily)
Terminated
- Asthma
- Placebo once daily
- +2 more
-
Newport Beach, California
- +120 more
Oct 7, 2021
Asthma Trial in Worldwide (QAW039, Montelukast, Placebo)
Completed
- Asthma
- QAW039
- +2 more
-
Scottsdale, Arizona
- +205 more
Dec 11, 2020
Nasal Polyps Trial in Worldwide (Fevipiprant 150 mg, Fevipiprant 450 mg, Placebo)
Completed
- Nasal Polyps
- Fevipiprant 150 mg
- +2 more
-
Irvine, California
- +24 more
Oct 7, 2021
Allergic Rhinitis Trial in Hannover (QAW039, Montelukast, Placebo)
Completed
- Allergic Rhinitis
- QAW039
- +2 more
-
Hannover, GermanyNovartis Investigative Site
Nov 16, 2016
Atopic Dermatitis Trial in Worldwide (QAW039, Placebo)
Completed
- Atopic Dermatitis
- QAW039
- Placebo
-
Phillip, Australian Capital Territory, Australia
- +17 more
Nov 11, 2015
Asthma Trial in Leicester (QAW039, Placebo)
Completed
- Asthma
- QAW039
- Placebo
-
Leicester, United KingdomNovartis Investigative Site
Oct 8, 2013